Business
Therini Bio raises nearly $40M to study DME and Alzheimer's immunotherapeutics
Funding to support two trials on fibrin-targeting immunotherapies targeting vascular dysfunction-induced neuroinflammation in severe retinal and neurological diseases.Pipeline
Viridian reports long-term durability data, secures FDA designation for TED therapy
After receiving FDA Breakthrough Therapy designation, new 52-week data finds 70% of proptosis responders at Week 15 maintained their response.Research
Researchers identify risk factors for unplanned OR visits post-cataract surgery
Study reports tamsulosin use as one of two key risk factors for postoperative complications.Products
FDA approves Genentech's Susvimo for DR
First sustained-release delivery system of ranibizumab earns third indication, with injections needed just once every 9 months.Pipeline
FDA clears Selagine's immunoglobulin DED drops for phase 2 trial
IND approval supports clinical development and evaluation of the anti-inflammatory and immunomodulatory biologic drug, potentially the first of its kind in the U.S.Products
Bausch + Lomb launches PF LUMIFY redness reliever drops
Newest preservative-free, OTC formulation of low-dose brimonidine tartrate is available in single-use vials to relieve eye redness due to minor ocular irritations.Business
Topcon invests in MedTech startup’s microdosing drug delivery system
Collaboration involves MistGo Digital, under clinical development as a drug delivery system combined with a digital adherence monitoring platform.Research
ADHD medication may lead to corneal cell changes in pediatric patients
Study notes differences in key parameters of corneal and retinal health in patients taking methylphenidate.Pipeline
FDA OKs clinical trial on Atia Vision's novel IOL for cataract patients
IDE approval brings company one step closer toward seeking regulatory clearance for the OmniVu Lens System, a dual-optic IOL.Pipeline
Atsena releases favorable LIGHTHOUSE trial data on XLRS gene therapy
Positive findings from 1-year post-treatment show meaningful improvements on visual function measurements, with foveal schisis closure observed in 67% of patients.Research
Air pollution exposure leading to more ocular disease cases among adults
Myopic eyes demonstrated increased risk of ocular disease with exposure to air pollution.Research
New alliance seeks a shift in healthcare via AI-based oculomics
Healthcare leader-led consortium Alliance for Healthcare from the Eye calls for a proactive healthcare approach, with a focus on prescreenings for ocular and systemic health.Business
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.Pipeline
Nicox releases favorable phase 3b data on IOP-lowering glaucoma therapeutic
Exploratory Whistler trial reports statistically significant IOP lowering and uveoscleral outflow for NCX 470, an NO-donating bimatoprost formulation.Research
How safe are iPSC-based RPE strip transplants for patients with RPE degeneration?
First clinical report of allogeneic iPSC-derived RPE strip transplantation demonstrated success in all three patients.Products
B+L launches Zenlens CHROMA HOA scleral contact lenses
Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.Research
New data supports Hoya's DIMS lenses for myopic prevention among preschool-aged pediatrics
Presented at ARVO, updated findings among the younger pre-myopics confirmed a protective effect of the patented and embedded technology on refractive status.Products
New World Medical launches upgraded Streamline Surgical System
Single-use, implant-free device offers surgeons improved visualization of key anatomical structures via a new transparent tip.Products
Zeiss debuts new research data platform for integrated workflows
Company’s cloud-based solution uses AI technology to integrate accessible clinical and research data into clinicians’ daily routines.Research